Catalyst Wire Dossier Catalyst Wire Dossier

KN060

· Suzhou Alphamab Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KN060, covering 2025-09-25 to 2025-10-01. Get the full timeline:

Most recent: Clinical Trial Update: To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients [Phase 1, Phase 2]

See pricing